Methylphenidate ER
Open Pre-Solicitation Posted
Not the latest version. See the latest solicitation from .
- Solicitation number
- SPE2D226R0013
- Agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Points of contact
Notice details come from SAM.gov. Updated .
About this opportunity
The Defense Logistics Agency Troop Support Medical intends to solicit a national requirements contract for Methylphenidate ER tablets, with solicitation expected in September 2026 and responses due by October 23, 2026. This is an unrestricted, fully competitive acquisition with no set-aside. The contract will be firm-fixed price, requirements type, with a one-year base and four one-year options. Methylphenidate ER will be procured in four dosages—18 mg, 27 mg, 36 mg, and 54 mg—in 100-count bottles. As a commercial item, the solicitation will use FAR Part 12 procedures. The resulting contract will establish a national supply source serving the Department of War, Department of Veterans Affairs, Indian Health Service, and Bureau of Prisons through DLA and VA prime vendor programs. Annual usage estimates will appear in the Schedule of Supplies section of the solicitation. DLA reserves the right to issue the solicitation before or after the projected September 2026 date. The solicitation will be posted to both the DLA Bid Board System (DIBBS) at https://www.dibbs.bsm.dla.mil and SAM.gov. Interested parties should contact Jeremy Brown at (445) 737-5419 or jeremy.brown@dla.mil with questions and are advised to set up automated notifications for pre-solicitation or solicitation changes.
Notice text
The Defense Logistics Agency is planning to issue a solicitation for a national requirements contract for Methylphenidate ER Tablets. Procurement details follow.
Methylphenidate ER 18MG, 27MG, 36MG, and 54MG Tablets in 100 count bottles.
This will be an unrestricted and fully competitive acquisition. The contract will be a firm-fixed price, requirements type contract with a one-year base and four one-year options. A contract resulting from this solicitation will establish a national supply source, in accordance with FAR 52.216-21 (Requirements), to provide the items listed in the schedule for purchase by Department of War, Department of Veterans Affairs, Indian Health Service and Bureau of Prisons customers through the DLA and VA prime vendor programs. The annual usage estimates will be provided in the Schedule of Supplies section of the solicitation. This is a commercial item and will be solicited using FAR part 12. All sources may submit a proposal which shall be considered by the agency.
A copy of the solicitation will be posted to the DLA Bid Board System (DIBBS) at https://www.dibbs.bsm.dla.mil and Sam.Gov at https://sam.gov. Interested parties should contact Jeremy Brown at (445) 737-5419, (jeremy.brown@dla.mil) for any questions/comments. Interested parties are further advised to set up automated notifications of pre-solicitation or solicitation changes through this website. The current projected solicitation date is September of 2026. DLA reserves the right to issue the solicitation before or after the projected solicitation date.
Notice history
| Notice | Type | Posted |
|---|---|---|
| Methylphenidate ER | Solicitation | |
| This notice | Pre-Solicitation |
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| Epinephrine Injector | Medical Supply Chain | No set-aside |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity